Lorence H. Kim, Chief Financial Officer at Moderna, Inc. (MRNA), sold 498,125 shares at $76.45 ($40.4M) on 2020-05-18, disclosed to the SEC on 2020-05-19.
Open-market sale of $40.4M MRNA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.96 | 5,442 | $354K | 0.9% |
| 2 | $64.96 | 5,442 | $354K | 0.9% |
| 3 | $66.05 | 9,715 | $642K | 1.6% |
| 4 | $66.05 | 9,715 | $642K | 1.6% |
| 5 | $66.68 | 2,243 | $150K | 0.4% |
| 6 | $66.68 | 2,243 |
| $150K |
| 0.4% |
| 7 | $76.45 | 3,768 | $288K | 0.7% |
| 8 | $76.45 | 3,768 | $288K | 0.7% |
| 9 | $77.48 | 7,640 | $592K | 1.5% |
| 10 | $77.48 | 7,640 | $592K | 1.5% |
| 11 | $79.40 | 18,675 | $1.5M | 3.7% |
| 12 | $80.24 | 35,569 | $2.9M | 7.1% |
| 13 | $80.24 | 35,569 | $2.9M | 7.1% |
| 14 | $81.43 | 16,736 | $1.4M | 3.4% |
| 15 | $81.43 | 16,736 | $1.4M | 3.4% |
| 16 | $82.28 | 56,379 | $4.6M | 11.5% |
| 17 | $82.28 | 56,379 | $4.6M | 11.5% |
| 18 | $83.33 | 59,175 | $4.9M | 12.2% |
| 19 | $83.33 | 59,175 | $4.9M | 12.2% |
| 20 | $84.27 | 33,792 | $2.8M | 7.1% |
| 21 | $84.27 | 33,792 | $2.8M | 7.1% |
| 22 | $85.16 | 5,868 | $500K | 1.2% |
| 23 | $85.16 | 5,868 | $500K | 1.2% |
| 24 | $86.54 | 2,600 | $225K | 0.6% |
| 25 | $86.54 | 2,600 | $225K | 0.6% |
| 26 | $86.96 | 798 | $69K | 0.2% |
| 27 | $86.96 | 798 | $69K | 0.2% |
| Total | $81.08 avg | 498,125 | $40.4M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-25 | $1.0M | — | Filing → |
| COWN | BUY | 2022-02-28 | $901K | — | Filing → |
| MRNA | SELL | 2020-06-04 | $14.1M | — | Filing → |